Modera Wealth Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.95M | Sell |
558,972
-5
| -0% | -$44 | 0.06% | 184 |
|
|
2025
Q1 | $4.38M | Sell |
558,977
-63,490
| -10% | -$497K | 0.06% | 188 |
|
|
2024
Q4 | $6.54M | Buy |
622,467
+18,501
| +3% | +$194K | 0.08% | 154 |
|
|
2024
Q3 | $7.92M | Buy |
603,966
+1,358
| +0.2% | +$17.8K | 0.1% | 129 |
|
|
2024
Q2 | $8.47M | Buy |
602,608
+2,159
| +0.4% | +$30.4K | 0.12% | 124 |
|
|
2024
Q1 | $10.1M | Buy |
600,449
+2,057
| +0.3% | +$34.7K | 0.15% | 111 |
|
|
2023
Q4 | $8.45M | Buy |
598,392
+4,392
| +0.7% | +$62K | 0.14% | 121 |
|
|
2023
Q3 | $6.12M | Hold |
594,000
| – | – | 0.12% | 128 |
|
|
2023
Q2 | $9.79M | Hold |
594,000
| – | – | 0.18% | 106 |
|
|
2023
Q1 | $5.44M | Hold |
594,000
| – | – | 0.21% | 57 |
|
|
2022
Q4 | $4.25M | Buy |
594,000
+48,000
| +9% | +$344K | 0.17% | 62 |
|
|
2022
Q3 | $2.74M | Buy |
546,000
+123,000
| +29% | +$616K | 0.14% | 77 |
|
|
2022
Q2 | $1.03M | Buy |
+423,000
| New | +$1.03M | 0.05% | 142 |
|